Vaccination against Meningococcal Group A Disease in Finland 1974–75

作者: Heikki Peltola , P. Helena Mäkelä , Olavi Elo , Ossi Pettay , Olli-Veikko Renkonen

DOI: 10.3109/INF.1976.8.ISSUE-3.09

关键词:

摘要: AbstractMeningococcal group A polysaccharide vaccine was used in children 3 months to 5 years of age the winter 1974–75 during an epidemic caused by sulphonamide-resistant meningococci. In provinces, offered on a double-blind basis, using Haemophilus influenzae type b as control. Approximately 100 000 were vaccinated with either one vaccines. Kymi province, approximately 22 representing 90% child population this received meningococcus vaccine. Infants below 18 booster dose after first dose. The local symptoms 71%, mild systemic reactions 37%, and high fever (38.5°C or more) 1.8%. haemophilus produced fewer side effects. No clinical infections meningococci reported 6 vaccination among those who had meningococcal At same time, case...

参考文章(8)
Malcolm S. Artenstein, Ronald Gold, Meningococcal infections: 2. Field trial of group C meningococcal polysaccharide vaccine in 1969-70 Bulletin of The World Health Organization. ,vol. 45, pp. 279- 282 ,(1971)
Gotschlich Ec, Boctar W, Amer A, el-Ghoroury Aa, Hablas R, Cvjetanović B, Sippel Je, Sanborn Wr, Rizk F, Wahdan Mh, el-Akkad Am, Triau R, Girgis Ni, A controlled field trial of a serogroup A meningococcal polysaccharide vaccine. Bulletin of The World Health Organization. ,vol. 48, pp. 667- 673 ,(1973)
A. A. Idris, H. H. Erwa, L. Lapeyssonnie, W. R. Sanborn, M. A. Haseeb, J. E. Sippel, A serogroup A meningococcal polysaccharide vaccine: studies in the Sudan to combat cerebrospinal meningitis caused by Neisseria meningitidis group A. Bulletin of The World Health Organization. ,vol. 49, pp. 301- 305 ,(1973)
Porter Anderson, Georges Peter, Richard B. Johnston, Leslie H. Wetterlow, David H. Smith, Immunization of Humans with Polyribophosphate, the Capsular Antigen of Hemophilus influenzae, Type b Journal of Clinical Investigation. ,vol. 51, pp. 39- 44 ,(1972) , 10.1172/JCI106794
Malcolm S. Artenstein, Ronald Gold, James G. Zimmerly, Frederic A. Wyle, Herman Schneider, Charles Harkins, Prevention of Meningococcal Disease by Group C Polysaccharide Vaccine New England Journal of Medicine. ,vol. 282, pp. 417- 420 ,(1970) , 10.1056/NEJM197002192820803
Irving Goldschneider, Emil C. Gotschlich, Malcolm S. Artenstein, Human immunity to the meningococcus. II. Development of natural immunity. Journal of Experimental Medicine. ,vol. 129, pp. 1327- 1348 ,(1969) , 10.1084/JEM.129.6.1327
Emil C. Gotschlich, Teh Yung Liu, Malcolm S. Artenstein, HUMAN IMMUNITY TO THE MENINGOCOCCUS : III. PREPARATION AND IMMUNOCHEMICAL PROPERTIES OF THE GROUP A, GROUP B, AND GROUP C MENINGOCOCCAL POLYSACCHARIDES Journal of Experimental Medicine. ,vol. 129, pp. 1349- 1365 ,(1969) , 10.1084/JEM.129.6.1349
P.Helena Mäkelä, Helena Käyhty, Pertti Weckström, Aulikki Sivonen, Olli-Veikko Renkonen, Effect of group-A meningococcal vaccine in army recruits in Finland. The Lancet. ,vol. 306, pp. 883- 886 ,(1975) , 10.1016/S0140-6736(75)92125-X